अApnaFunda

KREBS BIOCHEMICALS & INDUSTRIE (KREBSBIO)

Health Technology

Quality scoreHow the business itself ranks against its sector peers on profitability, 3-year growth and leverage. 50 is the middle of the sector.10 / 100
Profitability 18Growth 2
Share Price
₹56.60
ROCE
-15.0%
Market Cap
₹122 cr
Revenue (TTM)
₹25 cr
P/S
4.8x
Operating Margin
11.8%
Promoter Holding
72.7%
12M Momentum
-18.0%

52-week range

₹38.33₹76.85
47% of the way from its 52-week low to its high

Price risk

1Y volatility
57.3%
Beta vs sector
1-year daily
0.82

Balance sheet & cash

Interest cover
operating profit ÷ interest
-0.9x
Share count, 1Y
unchanged

What is the price implying?

Trailing earnings per share are negative, so a P/E-based figure does not exist. See the loss-makers list on the Expectations Gap page for a revenue-based version.

“Implied growth” is what the current price would require under our stated assumptions, not what we expect.

What prices imply across Health Technology The market-wide Expectations lists

What changed?

  1. Sep '26Moved into the 3rd quartile of Health Technology on operating margin (from the bottom quartile).
  2. Mar '26Fell 81% from the Jan 2022 peak to the Mar 2026 low.
  3. Apr '23Share count is up 10.0% over 12 months.
  4. Jun '22Revenue (TTM) reached a new high of ₹60 cr.
  5. Mar '22Share count is up 11.1% over 12 months.
  6. Aug '21Regained the 2020-12 peak, 5 months after the low.
  7. Jun '21Revenue (TTM) reached a new high of ₹54 cr.
  8. Mar '21Fell 39% from the Dec 2020 peak to the Mar 2021 low.
Show 4 earlier events
  1. Feb '21Share count is up 5.9% over 12 months.
  2. Dec '20Regained the 2019-01 peak, 9 months after the low.
  3. Mar '20Fell 50% from the Jan 2019 peak to the Mar 2020 low.
  4. Jan '20Share count is up 21.4% over 12 months.

Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.

Where price and fundamentals disagree, market-wide Rewind the whole market to any month

Are profits backed by cash?

2 of 3 checks are within range, 1 beyond a threshold.
Tap a check to see how it is measured.

Other income reliance—Not enough data

Not enough reported data to compute this.

Tax rate—Not enough data

Not enough reported data to compute this.

Cash conversion—Not enough data

Not enough reported data to compute this.

Free cash flow0 of 5 yrsBeyond threshold

Fiscal years with positive free cash flow in the last 5: 0. Bands: at least 80% of years, 40% to 80%, below 40%.

Receivable days vs history-4 daysWithin range

Debtor days are below the median of the previous three fiscal years by 4 days (0 vs 4). Bands: under 15 days, 15 to 45, over 45.

Capital work in progress1% of fixed assetsWithin range

Capital work-in-progress is 1% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.

Payable days—Not enough data

Not enough reported data to compute this.

How to read this

Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.

All terms explained in the glossary →

Who has been buying and selling?

  • Over 2 years, institutional and promoter holdings were broadly unchanged.
  • The number of shareholders fell from 8,990 to 8,521 (-5%) between Dec 2023 and Jun 2026.

Holdings, Jun '26

How each group changed

GroupDec '23Jun '26Change
Promoters72.7%72.7%0.0 pts
FIIs0.5%0.5%0.0 pts
DIIs———
Public and others26.8%26.8%0.0 pts

Number of shareholders

8,521shareholders-5% since Dec '23
9k9k9k9k Dec '23Sep '24Jun '25Jun '26
Dec '23: 8,990
Mar '24: 8,909
Sep '24: 9,425
Mar '25: 8,798
Jun '25: 9,118
Mar '26: 8,553
Jun '26: 8,521
9k9k9k9k Dec '23Sep '24Jun '25Jun '26
Dec '23: 8,990
Mar '24: 8,909
Sep '24: 9,425
Mar '25: 8,798
Jun '25: 9,118
Mar '26: 8,553
Jun '26: 8,521

Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.

This quarter's smart-money board

How rough has the ride been?

Maximum drawdown-81.3%not yet recovered
1-year volatility57.3%annualised

Monthly share price

₹40₹94₹147₹201 Jan '19Aug '20Mar '22Oct '23May '25Oct '26
2019-01: ₹97.70
2019-02: ₹88.55
2019-03: ₹114.45
2019-04: ₹95.80
2019-05: ₹88.65
2019-06: ₹79.00
2019-07: ₹68.15
2019-08: ₹67.15
2019-09: ₹86.05
2019-10: ₹92.75
2019-11: ₹94.50
2019-12: ₹77.85
2020-01: ₹90.10
2020-02: ₹95.00
2020-03: ₹77.75
2020-04: ₹72.15
2020-05: ₹77.90
2020-06: ₹76.20
2020-07: ₹90.25
2020-08: ₹84.55
2020-09: ₹89.80
2020-10: ₹86.90
2020-11: ₹94.40
2020-12: ₹139.05
2021-01: ₹119.05
2021-02: ₹113.45
2021-03: ₹85.95
2021-04: ₹127.00
2021-05: ₹122.55
2021-06: ₹117.80
2021-07: ₹130.80
2021-08: ₹158.30
2021-09: ₹173.00
2021-10: ₹157.70
2021-11: ₹166.10
2021-12: ₹201.35
2022-01: ₹168.40
2022-02: ₹140.65
2022-03: ₹143.05
2022-04: ₹151.70
2022-05: ₹115.85
2022-06: ₹103.35
2022-07: ₹119.95
2022-08: ₹131.75
2022-09: ₹112.15
2022-10: ₹118.70
2022-11: ₹108.35
2022-12: ₹109.65
2023-01: ₹100.80
2023-02: ₹67.60
2023-03: ₹56.50
2023-04: ₹71.00
2023-05: ₹65.85
2023-06: ₹70.75
2023-07: ₹72.60
2023-08: ₹67.65
2023-09: ₹68.00
2023-10: ₹68.95
2023-11: ₹81.90
2023-12: ₹78.35
2024-01: ₹75.55
2024-02: ₹72.75
2024-03: ₹61.45
2024-04: ₹71.35
2024-05: ₹62.00
2024-06: ₹70.95
2024-07: ₹93.48
2024-08: ₹84.04
2024-09: ₹80.36
2024-10: ₹81.91
2024-11: ₹104.14
2024-12: ₹92.99
2025-01: ₹99.38
2025-02: ₹78.88
2025-03: ₹66.37
2025-04: ₹74.11
2025-05: ₹75.37
2025-06: ₹87.80
2025-07: ₹78.39
2025-08: ₹71.25
2025-09: ₹70.63
2025-10: ₹69.04
2025-11: ₹67.40
2025-12: ₹69.04
2026-01: ₹58.82
2026-02: ₹57.04
2026-03: ₹39.75
2026-04: ₹59.67
2026-05: ₹65.16
2026-06: ₹60.13
2026-07: ₹53.65
2026-08: ₹56.29
2026-09: ₹60.20
2026-10: ₹56.60
₹40₹94₹147₹201 Jan '19Aug '21Mar '24Oct '26
2019-01: ₹97.70
2019-02: ₹88.55
2019-03: ₹114.45
2019-04: ₹95.80
2019-05: ₹88.65
2019-06: ₹79.00
2019-07: ₹68.15
2019-08: ₹67.15
2019-09: ₹86.05
2019-10: ₹92.75
2019-11: ₹94.50
2019-12: ₹77.85
2020-01: ₹90.10
2020-02: ₹95.00
2020-03: ₹77.75
2020-04: ₹72.15
2020-05: ₹77.90
2020-06: ₹76.20
2020-07: ₹90.25
2020-08: ₹84.55
2020-09: ₹89.80
2020-10: ₹86.90
2020-11: ₹94.40
2020-12: ₹139.05
2021-01: ₹119.05
2021-02: ₹113.45
2021-03: ₹85.95
2021-04: ₹127.00
2021-05: ₹122.55
2021-06: ₹117.80
2021-07: ₹130.80
2021-08: ₹158.30
2021-09: ₹173.00
2021-10: ₹157.70
2021-11: ₹166.10
2021-12: ₹201.35
2022-01: ₹168.40
2022-02: ₹140.65
2022-03: ₹143.05
2022-04: ₹151.70
2022-05: ₹115.85
2022-06: ₹103.35
2022-07: ₹119.95
2022-08: ₹131.75
2022-09: ₹112.15
2022-10: ₹118.70
2022-11: ₹108.35
2022-12: ₹109.65
2023-01: ₹100.80
2023-02: ₹67.60
2023-03: ₹56.50
2023-04: ₹71.00
2023-05: ₹65.85
2023-06: ₹70.75
2023-07: ₹72.60
2023-08: ₹67.65
2023-09: ₹68.00
2023-10: ₹68.95
2023-11: ₹81.90
2023-12: ₹78.35
2024-01: ₹75.55
2024-02: ₹72.75
2024-03: ₹61.45
2024-04: ₹71.35
2024-05: ₹62.00
2024-06: ₹70.95
2024-07: ₹93.48
2024-08: ₹84.04
2024-09: ₹80.36
2024-10: ₹81.91
2024-11: ₹104.14
2024-12: ₹92.99
2025-01: ₹99.38
2025-02: ₹78.88
2025-03: ₹66.37
2025-04: ₹74.11
2025-05: ₹75.37
2025-06: ₹87.80
2025-07: ₹78.39
2025-08: ₹71.25
2025-09: ₹70.63
2025-10: ₹69.04
2025-11: ₹67.40
2025-12: ₹69.04
2026-01: ₹58.82
2026-02: ₹57.04
2026-03: ₹39.75
2026-04: ₹59.67
2026-05: ₹65.16
2026-06: ₹60.13
2026-07: ₹53.65
2026-08: ₹56.29
2026-09: ₹60.20
2026-10: ₹56.60

Last 90 trading days

₹52₹57₹63₹68 Jun 23Jul 20Aug 13Sep 8Oct 6Oct 30
2026-06-23: ₹65.45
2026-06-25: ₹66.24
2026-06-30: ₹60.13
2026-07-02: ₹59.02
2026-07-06: ₹58.49
2026-07-08: ₹54.03
2026-07-10: ₹55.53
2026-07-14: ₹54.72
2026-07-16: ₹52.97
2026-07-20: ₹54.30
2026-07-22: ₹53.48
2026-07-24: ₹51.90
2026-07-28: ₹53.35
2026-07-30: ₹53.86
2026-08-03: ₹55.79
2026-08-05: ₹54.12
2026-08-07: ₹55.04
2026-08-11: ₹56.00
2026-08-13: ₹55.93
2026-08-17: ₹54.66
2026-08-19: ₹54.13
2026-08-21: ₹53.61
2026-08-25: ₹53.78
2026-08-27: ₹56.21
2026-08-31: ₹56.29
2026-09-02: ₹54.91
2026-09-04: ₹55.95
2026-09-08: ₹56.73
2026-09-10: ₹61.47
2026-09-15: ₹56.27
2026-09-17: ₹55.48
2026-09-21: ₹56.22
2026-09-23: ₹57.54
2026-09-25: ₹56.94
2026-09-29: ₹56.42
2026-10-01: ₹68.05
2026-10-06: ₹58.86
2026-10-08: ₹57.96
2026-10-12: ₹56.64
2026-10-14: ₹60.41
2026-10-16: ₹60.19
2026-10-21: ₹56.06
2026-10-23: ₹51.85
2026-10-27: ₹59.64
2026-10-29: ₹57.93
2026-10-30: ₹56.60
₹52₹57₹63₹68 Jun 23Aug 5Sep 17Oct 30
2026-06-23: ₹65.45
2026-06-25: ₹66.24
2026-06-30: ₹60.13
2026-07-02: ₹59.02
2026-07-06: ₹58.49
2026-07-08: ₹54.03
2026-07-10: ₹55.53
2026-07-14: ₹54.72
2026-07-16: ₹52.97
2026-07-20: ₹54.30
2026-07-22: ₹53.48
2026-07-24: ₹51.90
2026-07-28: ₹53.35
2026-07-30: ₹53.86
2026-08-03: ₹55.79
2026-08-05: ₹54.12
2026-08-07: ₹55.04
2026-08-11: ₹56.00
2026-08-13: ₹55.93
2026-08-17: ₹54.66
2026-08-19: ₹54.13
2026-08-21: ₹53.61
2026-08-25: ₹53.78
2026-08-27: ₹56.21
2026-08-31: ₹56.29
2026-09-02: ₹54.91
2026-09-04: ₹55.95
2026-09-08: ₹56.73
2026-09-10: ₹61.47
2026-09-15: ₹56.27
2026-09-17: ₹55.48
2026-09-21: ₹56.22
2026-09-23: ₹57.54
2026-09-25: ₹56.94
2026-09-29: ₹56.42
2026-10-01: ₹68.05
2026-10-06: ₹58.86
2026-10-08: ₹57.96
2026-10-12: ₹56.64
2026-10-14: ₹60.41
2026-10-16: ₹60.19
2026-10-21: ₹56.06
2026-10-23: ₹51.85
2026-10-27: ₹59.64
2026-10-29: ₹57.93
2026-10-30: ₹56.60

Drawdown from peak

0% -40% -79% Jan '19Dec '22Oct '26 0% -40% -79% Jan '19Dec '22Oct '26
Largest drawdowns

-81.3% (2022-01 peak to 2026-03 low, not yet recovered)

-50.1% (2019-01 peak to 2020-03 low, recovered 2020-12)

-39.3% (2020-12 peak to 2021-03 low, recovered 2021-08)

Where does it rank among Health Technology peers?

Each cell is the company's percentile rank among its Health Technology peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).

ROCE
Op. margin
Revenue growth
Cash cycle ↓
12M momentum
Nov '21Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25Jan '26Oct '26
Lower rank Higher rank

Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.

The Health Technology sector page Watch it move against Health Technology in the Observatory

What happened next to similar setups

−7.8%typical 12-month return vs the marketNot meaningfully different from the base rate
  • We found 50 past situations where a non-financial company looked like KREBS BIOCHEMICALS & INDUSTRIE today on valuation, return on capital, margins, debt, growth, price momentum, size and volatility.
  • Over the following 12 months the middle half of them returned −33% to +23% vs the market, against 0% for all non-financial companies in the same months.
  • The gap against the base rate (−7.9%, 80% range −20.5% to +0.7%) is within what chance and overlapping periods produce.

Where the 50 outcomes landed

−100%−50%0%+50%+100%
KAMOPAINTS · Apr 2024: −71.9% vs market
ORIENTALTL · Jun 2022: −56.2% vs market
SHAH · Sep 2020: −54.6% vs market
VIPULLTD · Jun 2021: −52.2% vs market
OMAXE · May 2022: −49.2% vs market
BALAJITELE · Mar 2022: −44.9% vs market
TICL · Feb 2025: −43.5% vs market
ASTEC · Aug 2025: −40.3% vs market
HCL-INSYS · Dec 2023: −36.1% vs market
REPRO · Nov 2021: −35.2% vs market
PNC · Jan 2024: −33.3% vs market
NEXTMEDIA · Dec 2021: −33.0% vs market
ENIL · Apr 2022: −32.7% vs market
PRAXIS · Dec 2021: −32.1% vs market
UFO · May 2022: −30.2% vs market
STCINDIA · Jul 2021: −28.7% vs market
INDOWIND · May 2020: −28.0% vs market
AHLEAST · Apr 2022: −25.2% vs market
EMAMIREAL · Nov 2023: −23.7% vs market
ZODIACLOTH · Apr 2022: −21.8% vs market
CCHHL · Dec 2021: −20.9% vs market
NOIDATOLL · Feb 2022: −15.0% vs market
INDIANCARD · Mar 2020: −11.6% vs market
TRF · Jun 2021: −10.3% vs market
BROOKS · Oct 2023: −8.3% vs market
ASIANHOTNR · Sep 2021: −7.2% vs market
BYKE · May 2022: −3.5% vs market
PALASHSECU · Jun 2022: −0.8% vs market
OILCOUNTUB · Jun 2020: +0.3% vs market
PRAENG · Feb 2024: +1.2% vs market
SMARTLINK · Sep 2020: +2.0% vs market
IITL · Mar 2022: +6.5% vs market
PREMEXPLN · Dec 2020: +7.3% vs market
IVC · Jun 2020: +9.0% vs market
KERNEX · Feb 2020: +10.7% vs market
MOTOGENFIN · Mar 2020: +13.1% vs market
ATLANTAA · Mar 2024: +18.6% vs market
ARROWGREEN · Apr 2021: +24.3% vs market
TREEHOUSE · Mar 2020: +26.1% vs market
SAFARI · Jul 2021: +39.5% vs market
DCM · Jun 2021: +58.2% vs market
ASIANENE · Jul 2023: +81.0% vs market
ORIENTHOT · Oct 2021: +85.9% vs market
INOXWIND · Nov 2022: +92.1% vs market
INVENTURE · May 2020: +94.5% vs market
DVL · Apr 2021: +96.2% vs market
SPECIALITY · Jul 2021: +133.3% vs market
ROHLTD · Mar 2022: +136.1% vs market
IMAGICAA · Jul 2021: +159.9% vs market
TEJASNET · Nov 2020: +215.2% vs market
Similar setups −7.8%All companies +0.1%← worse than the marketbetter than the market →

Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 4 beyond the range shown, drawn at the edge

Similar setups' median
−7.8%
All companies' median
+0.1%
Beat the market
44% vs 50%

50 past situations · 50 companies · 30 months · 2020–2025

The closest matches

CompanyWhenP/EROCE12M mom.DrawdownNext 12 months
NEXTMEDIA
Consumer Services
Dec 2021 —-29% +53%−9% −33%
NOIDATOLL
Commercial Services
Feb 2022 —-10% +30%−17% −15%
KERNEX
Electronic Technology
Feb 2020 —-15% −9%−28% +11%
ARROWGREEN
Process Industries
Apr 2021 —-12% +101%−13% +24%
OILCOUNTUB
Non-Energy Minerals
Jun 2020 —-34% −24%−34% 0%
Show the other 3 matches
CompanyWhenP/EROCE12M mom.DrawdownNext 12 months
BROOKS
Health Technology
Oct 2023 —-30% +6%−11% −8%
IVC
Finance
Jun 2020 —-8% −17%−21% +9%
IMAGICAA
Consumer Services
Jul 2021 —-18% +93%−5% +160%
How reliable is this?

Matched on P/S, ROCE, operating margin, interest cover, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: 12-month momentum, drawdown from 12-month high and interest cover. Not used (unavailable for this company): P/E and debt/equity. This company is loss-making, so it was only compared with loss-making companies. One match per company and at most 7 from any one month.

Independent periods: the matches fall in 5 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.

How this is built

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to KREBS BIOCHEMICALS & INDUSTRIE. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

Methodology

How historical analogs are built

Data as of 2026-10-30. Outcome pool: Jan 2020 to Oct 2025.

For every company we look at the situation it is in today (valuation, return on capital, margins, debt, growth, 12-month price momentum, drawdown, size and volatility) and find past company-months that looked most like it. We then show what happened to those past situations over the following 12 months, measured against the ApnaFunda All index and against the base rate. It describes history. It does not predict anything.

What is compared

FeatureWeightNon-financialFinancial
P/E1yesyes
P/S1yes—
P/B1—yes
ROCE1yes—
operating margin1yes—
ROE1—yes
debt/equity0.75yes—
interest cover0.5yes—
revenue growth0.75yesyes
12-month momentum1yesyes
drawdown from 12-month high0.75yesyes
size0.75yesyes
volatility0.5yesyes

Weights were set by judgement before any outcome was looked at and are never tuned on results. Loss-making companies (negative P/E or net profit) are only matched with other loss-making companies. Banks, NBFCs and insurers are compared only with each other and use a different feature set. Every feature is converted, month by month, to its rank among companies in the same pool in that month, so a P/E of 30 in a hot market and a P/E of 22 in a cold one can match if both were equally expensive for their time. Only that month's data is used.

How closeness and the sample are defined

Distance is the weighted root-mean-square gap between the standardised features both companies have. A match needs at least 70% of the query's feature weight, a distance of at most 0.9, and 30 matches at minimum to be shown. We keep up to 50 matches with these exclusions: never the company itself, one match per company (its closest month), and at most 7 from any one calendar month so a single market episode cannot dominate.

Base rate

The base rate is the distribution of 12-month returns, relative to the market, of every eligible company-month in the same pool, with each month weighted to match the months the analogs came from. It answers: how did a random company do in these same months? Because matches from nearby months share the same market conditions, we also report the number of distinct 12-month windows behind a result, and a bootstrap that resamples months decides whether the analog median differs from the base rate at all. "Not meaningfully different" is the usual outcome and the page copy is written for it.

Limits you should know

  • One market period. The outcome pool covers 2020–2025 only (70 months), including the 2020 crash and the 2020–21 rally.
  • Survivorship. Only companies listed today are included. Delisted and bankrupt companies are missing, which flatters past outcomes, particularly for distressed-looking setups.
  • Price return only. Dividends are excluded, and the benchmark is an ApnaFunda market-cap-weighted index of the same listed companies, not an official index.
  • Reporting lag. Fundamentals are matched on an assumed 60-day lag after the quarter end, not on real announcement dates.
  • Pools: non-financial: 97,430 company-months from 2000 companies; financial: 5,632 company-months from 106 companies. 2240 companies currently have a result; the rest are suppressed because too few comparable situations exist.

Does it work? A walk-forward check

The walk-forward check has not been run for this build, so skill is shown as not yet measured.

Disclaimer

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to any company shown. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.
Monthly history (94 months)
MonthRevenue (TTM)ROCE
2026-10₹25 cr-15.0%
2026-09₹25 cr-15.0%
2026-08₹24 cr-15.0%
2026-07₹24 cr-15.0%
2026-06₹24 cr-15.0%
2026-05₹23 cr-30.0%
2026-04₹23 cr-30.0%
2026-03₹23 cr-30.0%
2026-02₹27 cr-30.0%
2026-01₹27 cr-30.0%
2025-12₹27 cr-30.0%
2025-11₹36 cr-30.0%
2025-10₹36 cr-30.0%
2025-09₹36 cr-30.0%
2025-08₹43 cr-30.0%
2025-07₹43 cr-30.0%
2025-06₹43 cr-30.0%
2025-05₹49 cr-19.0%
2025-04₹49 cr-19.0%
2025-03₹49 cr-19.0%
2025-02₹51 cr-19.0%
2025-01₹51 cr-19.0%
2024-12₹51 cr-19.0%
2024-11₹53 cr-19.0%
2024-10₹53 cr-19.0%
2024-09₹53 cr-19.0%
2024-08₹50 cr-19.0%
2024-07₹50 cr-19.0%
2024-06₹50 cr-19.0%
2024-05₹52 cr-29.0%
2024-04₹52 cr-29.0%
2024-03₹52 cr-29.0%
2024-02₹52 cr-29.0%
2024-01₹52 cr-29.0%
2023-12₹52 cr-29.0%
2023-11₹52 cr-29.0%
2023-10₹52 cr-29.0%
2023-09₹52 cr-29.0%
2023-08₹52 cr-29.0%
2023-07₹52 cr-29.0%
2023-06₹52 cr-29.0%
2023-05₹60 cr-57.0%
2023-04₹60 cr-57.0%
2023-03₹60 cr-57.0%
2023-02₹60 cr-57.0%
2023-01₹60 cr-57.0%
2022-12₹60 cr-57.0%
2022-11₹60 cr-57.0%
2022-10₹60 cr-57.0%
2022-09₹60 cr-57.0%
2022-08₹60 cr-57.0%
2022-07₹60 cr-57.0%
2022-06₹60 cr-57.0%
2022-05₹54 cr-40.0%
2022-04₹54 cr-40.0%
2022-03₹54 cr-40.0%
2022-02₹54 cr-40.0%
2022-01₹54 cr-40.0%
2021-12₹54 cr-40.0%
2021-11₹54 cr-40.0%
2021-10₹54 cr-40.0%
2021-09₹54 cr-40.0%
2021-08₹54 cr-40.0%
2021-07₹54 cr-40.0%
2021-06₹54 cr-40.0%
2021-05₹33 cr-57.0%
2021-04₹33 cr-57.0%
2021-03₹33 cr-57.0%
2021-02₹33 cr-57.0%
2021-01₹33 cr-57.0%
2020-12₹33 cr-57.0%
2020-11₹33 cr-57.0%
2020-10₹33 cr-57.0%
2020-09₹33 cr-57.0%
2020-08₹33 cr-57.0%
2020-07₹33 cr-57.0%
2020-06₹33 cr-57.0%
2020-05₹48 cr-36.0%
2020-04₹48 cr-36.0%
2020-03₹48 cr-36.0%
2020-02₹48 cr-36.0%
2020-01₹48 cr-36.0%
2019-12₹48 cr-36.0%
2019-11₹48 cr-36.0%
2019-10₹48 cr-36.0%
2019-09₹48 cr-36.0%
2019-08₹48 cr-36.0%
2019-07₹48 cr-36.0%
2019-06₹48 cr-36.0%
2019-05₹34 cr-26.0%
2019-04₹34 cr-26.0%
2019-03₹34 cr-26.0%
2019-02₹34 cr-26.0%
2019-01₹34 cr-26.0%

Methodology and data notes

Methodology

Methodology and data notes

All figures come from public exchange prices and screener.in financial statements. Quarterly and annual results are shown from 60 days after the period end, so a month never uses a result before it would plausibly have been published. Statements are the latest versions, which may include later restatements.

Sector medians, percentiles and indices use today's listed companies in the sector (survivorship bias). Prices are adjusted for splits and bonus issues; around a corporate action the fundamentals may lag the price by up to a month, and affected sections are hidden.

The return decomposition uses price = P/E × net profit ÷ share count. The reverse DCF uses a fixed 12% cost of equity, a 10-year horizon and a 15x terminal P/E, and is an illustration only. Events, flags and twins follow fixed rules and thresholds described next to each section.

Feedback